➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
McKinsey
Harvard Business School
Moodys

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

COPEGUS Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Copegus, and when can generic versions of Copegus launch?

Copegus is a drug marketed by Roche and is included in one NDA.

The generic ingredient in COPEGUS is ribavirin. There are fifteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the ribavirin profile page.

US ANDA Litigation and Generic Entry Outlook for Copegus

A generic version of COPEGUS was approved as ribavirin by ZYDUS PHARMS USA on October 28th, 2005.

  Start Trial

Summary for COPEGUS
Drug patent expirations by year for COPEGUS
Recent Clinical Trials for COPEGUS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Weill Medical College of Cornell UniversityEarly Phase 1
Chugai PharmaceuticalN/A
Gilead SciencesN/A

See all COPEGUS clinical trials

US Patents and Regulatory Information for COPEGUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche COPEGUS ribavirin TABLET;ORAL 021511-001 Dec 3, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Roche COPEGUS ribavirin TABLET;ORAL 021511-002 Jun 21, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
McKinsey
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.